Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Piazza

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Cancers|June 19, 2024
<i>N</i>-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer AgentsNoha Mostafa, Po-Jen Chen, Sarah S Darwish, et al.
Molecular Oncology|December 2, 2011
Aquaporins mediate the chemoresistance of human melanoma cells to arseniteLin Gao, Yanhui Gao, Xiaobo Li, et al.
Drug Discovery Today|June 21, 2020
PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunityGary A Piazza, Antonio Ward, Xi Chen, et al.
Journal of Experimental Therapeutics & Oncology|June 26, 2003
Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cellsAndrew K Joe, Hui Liu, Danhua Xiao, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
NSAIDs: Old Drugs Reveal New Anticancer TargetsGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Arzneimittel-Forschung|October 10, 2009
Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agentsAshraf H Abadi, Dalal A Abouel-Ella, Nermin S Ahmed, et al.
Drug Design, Development and Therapy|August 30, 2017
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profilingHatem A Abdel-Aziz, Wagdy M Eldehna, Adam B Keeton, et al.
Advances in Cancer Research|February 1, 2022
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stoneAlexander B Coley, Antonio Ward, Adam B Keeton, et al.
The Journal of Biological Chemistry|June 7, 2013
An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4Sumit Arora, Arun Bhardwaj, Seema Singh, et al.
Experimental Neurology|November 16, 2024
A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's diseaseSara El-Desouky, Mohammad Abdel-Halim, Reem K Fathalla, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Cancers|June 19, 2024
<i>N</i>-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer AgentsNoha Mostafa, Po-Jen Chen, Sarah S Darwish, et al.
Molecular Oncology|December 2, 2011
Aquaporins mediate the chemoresistance of human melanoma cells to arseniteLin Gao, Yanhui Gao, Xiaobo Li, et al.
Drug Discovery Today|June 21, 2020
PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunityGary A Piazza, Antonio Ward, Xi Chen, et al.
Journal of Experimental Therapeutics & Oncology|June 26, 2003
Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cellsAndrew K Joe, Hui Liu, Danhua Xiao, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
NSAIDs: Old Drugs Reveal New Anticancer TargetsGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Arzneimittel-Forschung|October 10, 2009
Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agentsAshraf H Abadi, Dalal A Abouel-Ella, Nermin S Ahmed, et al.
Drug Design, Development and Therapy|August 30, 2017
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profilingHatem A Abdel-Aziz, Wagdy M Eldehna, Adam B Keeton, et al.
Advances in Cancer Research|February 1, 2022
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stoneAlexander B Coley, Antonio Ward, Adam B Keeton, et al.
The Journal of Biological Chemistry|June 7, 2013
An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4Sumit Arora, Arun Bhardwaj, Seema Singh, et al.
Experimental Neurology|November 16, 2024
A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's diseaseSara El-Desouky, Mohammad Abdel-Halim, Reem K Fathalla, et al.
Pageof 12